Mostrar el registro sencillo del ítem

Artículo

dc.creatorElhalem, Eleonoraes
dc.creatorRecio Jiménez, Rocíoes
dc.creatorWerner, Sabinees
dc.creatorLieder, Franziskaes
dc.creatorCalderón Montaño, José Manueles
dc.creatorLópez Lázaro, Migueles
dc.creatorFernández Fernández, Inmaculadaes
dc.creatorKhiar, Noureddinees
dc.date.accessioned2018-02-05T17:11:09Z
dc.date.available2018-02-05T17:11:09Z
dc.date.issued2014
dc.identifier.citationElhalem, E., Recio Jiménez, R., Werner, S., Lieder, F., Calderón Montaño, J.M., López Lázaro, M.,...,Khiar, N. (2014). Sulforaphane homologues: Enantiodivergent synthesis of both enantiomers, activationof the Nrf2 transcription factor and selective cytotoxic activity. European Journal of Medicinal Chemistry, 87, 552-563.
dc.identifier.issn0223-5234es
dc.identifier.urihttps://hdl.handle.net/11441/69980
dc.description.abstractReported is an enantiodivergent approach for the synthesis of both enantiomers of sulforaphane (SFN) homologues with different chain lengths between the sulfinyl sulfur and the isothiocyanate groups and different substituents on the sulfinyl sulfur. The homologues were designed in order to unravel the effect of all the diversity elements included in sulforaphane's structure. The key step of the approach is the diastereoselective synthesis of both sulfinate ester epimers at sulfur, using as single chiral auxiliary the sugar derived diacetone-d-glucose. The approach allows the first synthesis of both enantiomers of 5-methylsulfinylpentyl isothiocyanate, and the biologically important 6-methylsulfinylhexyl isothiocyanate (6-HITC) found in Japanese horseradish, wasabi (Wasabia japonica). The ability of the synthesized compounds as inductors of phase II detoxifying enzymes has been studied by determining their ability to activate the cytoprotective transcription factor Nrf2. The cytotoxic activity of all the synthesized compounds against human lung adenocarcinoma (A549) and foetal lung fibroblasts (MRC-5) is also reported. Both enantiomers of sulforaphane and six homologues were obtained.The ability of the synthesized compounds to activate the Nrf2 is studied.The cytotoxic activity of the analogues against cancer and healthy cells is reported.es
dc.description.sponsorshipMinisterio de Economía y Competitividad CTQ2010-21755-CO2-02es
dc.description.sponsorshipJunta de Andalucía P11-FQM-8046es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofEuropean Journal of Medicinal Chemistry, 87, 552-563.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCytotoxic activityes
dc.subjectDAG-methodologyes
dc.subjectActivation of Nrf2 factores
dc.subjectEnantiodivergent synthesises
dc.subjectR and S Sulforaphane and Homologueses
dc.titleSulforaphane homologues: Enantiodivergent synthesis of both enantiomers, activationof the Nrf2 transcription factor and selective cytotoxic activityes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/submittedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Orgánica y Farmacéuticaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacologíaes
dc.relation.projectIDCTQ2010-21755-CO2-02es
dc.relation.projectIDP11-FQM-8046es
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.ejmech.2014.09.052es
dc.identifier.doi10.1016/j.ejmech.2014.09.052es
idus.format.extent51 p.es
dc.journaltitleEuropean Journal of Medicinal Chemistryes
dc.publication.volumen87es
dc.publication.initialPage552es
dc.publication.endPage563es
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). España
dc.contributor.funderJunta de Andalucía

FicherosTamañoFormatoVerDescripción
Sulforaphane Homologues.pdf959.7KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional